Nanoantibodies

November 20, 2025

Posted by Communication - IIS Aragón el November 20, 2025

How do dromedaries contribute to fighting prostate cancer?

We share this news from Gaceta de Salud about the research led by Alberto Jiménez Schuhmacher in which nanoantibodies derived from dromedary proteins have been developed to create “drones” capable of locating and attacking prostate cancer cells.

August 19, 2025

Posted by Communication - IIS Aragón el August 19, 2025

Sara Project at the IIS Aragón: the challenge of developing more potent and less harmful cancer drugs

Developed by the Molecular Oncology Group at the IIS Aragón, led by Alberto J. Schuhmacher, it is based on an innovative technology that uses nanobodies derived from dromedaries.

August 20, 2024

Posted by Communication - IIS Aragón el August 20, 2024

The magazine Cancers highlights a review article on therapies from the Molecular Oncology group of the IIS Aragón

The work has been dedicated to Professor María Victoria Arruga, who recently died, and who was the "teacher" of the researcher Alberto J. Schuhmacher. The article was one of the five highlighted among the 157 in the latest issue of the magazine on its website.